1.55% -0.11

Relmada Therapeutics Inc (RLMD)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Relmada Therapeutics Inc Azioni (RLMD) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	1.04% 10.33	10.22	18.22	19.08	23.01
Operating Income/Loss	1.04% -10.33	-10.22	-18.22	-19.08	-23.01
Nonoperating Income/Loss	33.54% 0.2359	0.3549	0.659	0.4184	1.2829
Income/Loss From Continuing Operations Before Tax	2.28% -10.09	-9.8664	-17.56	-18.66	-21.73
Income/Loss From Continuing Operations After Tax	2.28% -10.09	-9.8664	-17.56	-18.66	-21.73
Net Income/Loss	2.28% -10.09	-9.8664	-17.56	-18.66	-21.73
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.00% 33.19	33.19	30.41	0.00351	30.17
Diluted Average Shares	0.00% 33.19	33.19	30.41	0.00351	30.17
Basic Earnings Per Share	0.00% -0.30	-0.30	-0.58	-0.62	-0.72
Diluted Earnings Per Share	0.00% -0.30	-0.30	-0.58	-0.62	-0.72
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RVMD

$99.12

0.49%

ROIV

$28.33

1.76%

RPRX

$48.57

0.16%

BNTX

$91.18

1.97%

ONC

$310.79

0.76%

INSM

$162.43

1.47%